A new class of stents may expand treatment options for patients with peripheral arterial disease.
By Craig M. Walker, MD
A new trial cautions against combined antiplatelet therapy and anticoagulation in treating PAD.
By Ravi K. Veeraswamy, MD, and Ross Milner, MD
An appraisal of prospective randomized clinical trials.
By Peter H. Lin, MD; Tam T. Huynh, MD; Panagiotis Kougias, MD; and Hosam F. El-Sayed, MD
Of signal importance in carotid artery stenting.
By William A. Gray, MD
A look at the factors contributing to the slower-than-anticipated growth of carotid artery stenting in the US.
By Gary S. Roubin, MD, PHD
John H. Rundback, MD, of the TACIT trial, and Sumaira Macdonald, MD, of ACST-2 discuss the necessary elements to evaluate the current state of care for treating asymptomatic carotid stenosis.
By John H. Rundback, MD and Sumaira Macdonald, MBChB (Comm.), FRCP, FRCR, PhD
CHIEF MEDICAL EDITOR’S PAGE
By Barry T. Katzen, MD, Chief Medical Editor
Meeting the challenges of a randomized clinical trial.
By Susan E. Hughes, BSN; MeeLee Tom, MS; Mary E. Longbottom, BA; Alice J. Sheffet, PhD; Thomas G. Brott, MD; and Robert W. Hobson II, MD
Frank Arko, MD; Ali Azizzadeh, MD, FACS; and Rodney White, MD, discuss the AneuRx 5-year data, how they compare to their own experiences, and the future implications for physicians.
By Frank Arko, MD; Ali Azizzadeh, MD, FACS; and Rodney White, MD
From the Cleveland Clinic to Abu Dhabi, Dr. Ouriel discusses his new role, differences in device regulation, and the exciting pace at which medicine changes in the UAE.